Recalls / Active ingredient / Dexamethasone Sodium Phosphate
Dexamethasone Sodium Phosphate
4 FDA drug recalls involving the active ingredient “Dexamethasone Sodium Phosphate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2026-02-04 | Class II | Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx onl | SOMERSET THERAPEUTICS LLC |
| 2024-05-23 | Class II | Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Dist | Eugia US LLC |
| 2017-11-06 | Class III | Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01), packaged in 25 x 1 mL V | West-Ward Pharmaceuticals Corp. |
| 2017-11-06 | Class III | Dexamethasone Sodium Phosphate Injection, USP, 20 mg/5 mL (4 mg/mL), 5 mL Vials (NDC 0641-6146-01), packaged i | West-Ward Pharmaceuticals Corp. |